Evaluation of dexamethasone effects in COVID-19 treatment
Keywords:
coronavirus, COVID-19, dexamethasone, treatmentAbstract
(COVID-19) Finding a cure for Corona virus sickness in 2019 will be a difficult task for researchers all over the globe, since it is associated with significant lung damage and the potential for multiple organ failure. To far, dexamethasone has shown substantial benefits in COVID-19, reducing mortality while improving recovery. There is a reduction in inflammation due to a reduction in inflammation-related immune responses and a decrease in cytokine production, which prevents COVID-19 from becoming more severe. Dexamethasone's significance in the treatment of COVID-19 is currently unproven. When it comes to combating this pandemic, COVID-19's pathophysiology and dexamethasone's efficacy are the deciding factors.
Downloads
References
Abraham, S. M., Lawrence, T., Kleiman, A., Warden, P., Medghalchi, M., Tuckermann, J., ... & Clark, A. R. (2006). Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. The Journal of experimental medicine, 203(8), 1883-1889.
Calabrese, F., Pezzuto, F., Fortarezza, F., Hofman, P., Kern, I., Panizo, A., ... & Lunardi, F. (2020). Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists. Virchows archiv, 477(3), 359-372.
Corman, VM, Lienau, J., & Witzenrath, M. (2019). Corona viruses as a cause of respiratory infections. The Internist , 60 (11), 1136-1145.
Florindo, H. F., Kleiner, R., Vaskovich-Koubi, D., Acúrcio, R. C., Carreira, B., Yeini, E., ... & Satchi-Fainaro, R. (2020). Immune-mediated approaches against COVID-19. Nature nanotechnology, 15(8), 630-645.
Gyamfi-Bannerman, C., Thom, E. A., Blackwell, S. C., Tita, A. T., Reddy, U. M., Saade, G. R., ... & Jain, L. (2016). Antenatal betamethasone for women at risk for late preterm delivery. New England Journal of Medicine, 374(14), 1311-1320.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., ... & Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
Ibrahim, H. K., Mohammed, A. A., & Omar, O. A. (2018). Effects of Antibiotics (Ciprofloxacin–Augmentin–Gentamicin–Norfloxacin–Ampicillin) which are used for Treatment of Urinary Tract Infections in Female Patients. V, Issue, 10.
Johnson, D. B., Lopez, M. J., & Kelley, B. (2018). Dexamethasone.
Khaliha, H., Saed, A., & Daw, S. (2020). Hydroxychloroquine And Dexamethasone Are Both Possible For Treatment Of Covid-19.
Kolias, A. G., Edlmann, E., Thelin, E. P., Bulters, D., Holton, P., Suttner, N., ... & Hutchinson, P. J. (2018). Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial. Trials, 19(1), 1-14.
Ledford, H. (2020). Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature, 582(7813), 469-470.
Liggins, G. C., & Howie, R. N. (1972). A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics, 50(4), 515-525.
Mahase, E. (2020). Covid-19: demand for dexamethasone surges as RECOVERY trial publishes preprint. BMJ: British Medical Journal (Online), 369.
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020). COVID-19: consider cytokine storm syndromes and immunosuppression. The lancet, 395(10229), 1033-1034.
Momattin, H., Al-Ali, A. Y., & Al-Tawfiq, J. A. (2019). A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Travel medicine and infectious disease, 30, 9-18. https://doi.org/10.1016/j.tmaid.2019.06.012
Ogbru, O. (2020). Decadron (Dexamethasone): COVID-19 Coronavirus Drug. MedicineNet.
Rhen, T., & Cidlowski, J. A. (2005). Antiinflammatory action of glucocorticoids—new mechanisms for old drugs. New England Journal of Medicine, 353(16), 1711-1723.
Sibila, O., Luna, C. M., Agusti, C., Baquero, S., Gando, S., Patrón, J. R., ... & Torres, A. (2008). Effects of glucocorticoids in ventilated piglets with severe pneumonia. European Respiratory Journal, 32(4), 1037-1046.
Siddiqi, H. K., & Mehra, M. R. (2020). COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal. The journal of heart and lung transplantation, 39(5), 405-407.
World Health Organization. (2019). World Health Organization model list of essential medicines: 21st list 2019 (No. WHO/MVP/EMP/IAU/2019.06). World Health Organization.
Yasir, M., Goyal, A., Bansal, P., & Sonthalia, S. (2018). Corticosteroid adverse effects.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.